Insights from 2023 ESMO Annual Meeting

 

Gynecologic
08:29

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "innovaTV 301/ENGOT-cx12/GOG-3057 Study - Tisotumab Vedotin vs. Investigator’s Choice of Chemo in 2L/3L Recurrent or Metastatic Cervical Cancer"

FEATURING Susana Banerjee
  • 63 views
  • December 13, 2023
11:10

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "KEYNOTE-A18 Study - Pembro + CRT for High-Risk Locally Advanced Cervical Cancer"

FEATURING Domenica Lorusso
  • 193 views
  • November 24, 2023
17:11

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "AtTEnd Trial of Atezo in Combination With Carboplatin & Paclitaxel in Women With Advanced/Recurrent Endometrial Carcinoma"

FEATURING Nicoletta Colombo
  • 124 views
  • November 10, 2023
12:45

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The GCIG INTERLACE Randomised Phase 3 Trial of Induction Chemo Followed by CRT Compared With CRT Alone in Locally Advanced Cervical Cancer"

FEATURING Mary McCormack
  • 328 views
  • October 26, 2023
  • 3
14:09

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Phase 3 DUO-E/GOG-3041/ENGOT-EN10 Trial - Durvalumab + Carboplatin/Paclitaxel Followed by Maintenance Durvalumab±Olaparib for Newly Diagnosed Advanced/Recurrent Endometrial Cancer"

FEATURING Shannon Westin
  • 274 views
  • October 26, 2023
06:07

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

FEATURING Mansoor Raza Mirza
  • 1,014 views
  • October 26, 2023
  • 3
09:29

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Phase 3 RUBY Trial - Dostarlimab + Chemotherapy for the Treatment of Primary Advanced or Recurrent Endometrial Cancer - Analysis of PFS & OS Outcomes by Molecular Classification"

FEATURING Mansoor Raza Mirza
  • 336 views
  • October 26, 2023